These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2763988)

  • 1. Addiction to tranylcypromine (Parnate): a case report.
    Westermeyer J
    Am J Drug Alcohol Abuse; 1989; 15(3):345-50. PubMed ID: 2763988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranylcypromine withdrawal phenomena.
    Halle MT; Dilsaver SC
    J Psychiatry Neurosci; 1993 Jan; 18(1):49-50. PubMed ID: 8461282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Oostervink F; Bouvy PF; Touw DJ
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1937-40. PubMed ID: 14574773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranylcypromine addiction: a case report and review.
    Briggs NC; Jefferson JW; Koenecke FH
    J Clin Psychiatry; 1990 Oct; 51(10):426-9. PubMed ID: 2211541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dependence on monoamine oxidase inhibitors in high dose.
    Vartzopoulos D; Krull F
    Br J Psychiatry; 1991 Jun; 158():856-7. PubMed ID: 1873639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abuse of monoamine oxidase inhibitors.
    Briggs NC; Jefferson JW
    Am J Drug Alcohol Abuse; 1994; 20(1):125. PubMed ID: 8192131
    [No Abstract]   [Full Text] [Related]  

  • 8. Symptoms of major depression: acute effect of withdrawing antidepressants.
    Halle MH; Del Medico VJ; Dilsaver SC
    Acta Psychiatr Scand; 1991 Mar; 83(3):238-9. PubMed ID: 2031468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranylcypromine abuse associated with an isolated thrombocytopenia.
    Szelényi A; Albrecht J
    Pharmacopsychiatry; 1998 Nov; 31(6):238-40. PubMed ID: 9930640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peaked "T" waves with tranylcypromine (parnate) overdose.
    Quill TE
    Int J Psychiatry Med; 1981-1982; 11(2):155-60. PubMed ID: 7263132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of tranylcypromine ('Parnate') addiction.
    Ben-Arie O; George GC
    Br J Psychiatry; 1979 Sep; 135():273-4. PubMed ID: 486854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High dosage tranylcypromine treatment of "therapy refractory" depressions].
    Schmauss M
    Nervenarzt; 1996 May; 67(5):390-3. PubMed ID: 9005348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranylcypromine abuse: cause for concern?
    Lichtigfeld FJ; Gillman MA
    Am J Psychiatry; 1992 Jul; 149(7):989. PubMed ID: 1609897
    [No Abstract]   [Full Text] [Related]  

  • 16. ["Addiction" to phenelzine - case report].
    Antosik-Wójcińska AZ; Bzinkowska D; Chojnacka M; Swiecicki Ł; Torbiński J
    Psychiatr Pol; 2013; 47(1):127-34. PubMed ID: 23888750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of tranylcypromine-induced hallucination].
    Hoffmann W
    Psychiatr Prax; 1993 May; 20(3):116. PubMed ID: 8378483
    [No Abstract]   [Full Text] [Related]  

  • 19. Delirium, thrombocytopenia, insomnia, and mild liver damage associated with MAOI withdrawal.
    Bellon A; Coverdale JH
    Eur J Clin Pharmacol; 2009 Dec; 65(12):1269-70. PubMed ID: 19655131
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mianserin-induced hypertension 2 weeks after discontinuation of tranylcypromine].
    Bottlender R; Erfurth A; Hoff P; Möller HJ
    Nervenarzt; 1997 Jul; 68(7):591-2. PubMed ID: 9333722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.